Literature DB >> 16998508

Reciprocal regulation between natural killer cells and autoreactive T cells.

Fu-Dong Shi1, Luc Van Kaer.   

Abstract

The initiation and the progression of autoimmune diseases stem from complex interactions that involve cells of both the innate and the adaptive immune system. As we discuss here, natural killer (NK) cells, which are components of the innate immune system, can inhibit or promote the activation of autoreactive T cells during the initiation of autoimmunity. After they have been activated, autoreactive T cells contribute to the homeostatic contraction of NK-cell populations. The dynamic interaction between NK cells and autoreactive T cells might indicate the transition from the innate immune triggering of autoimmunity to the progressive phase of the disease. Understanding the mechanisms and signals that control the reciprocal regulation of NK cells and autoreactive T cells could have important implications for treatment in the clinic.

Entities:  

Mesh:

Year:  2006        PMID: 16998508     DOI: 10.1038/nri1935

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  53 in total

1.  Lysosomal alpha-galactosidase controls the generation of self lipid antigens for natural killer T cells.

Authors:  Alexandre Darmoise; Susann Teneberg; Lauriane Bouzonville; Roscoe O Brady; Michael Beck; Stefan H E Kaufmann; Florian Winau
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

Review 2.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

3.  Altered innate immunity following spinal cord injury.

Authors:  D I Campagnolo; D Dixon; J Schwartz; J A Bartlett; S E Keller
Journal:  Spinal Cord       Date:  2008-02-12       Impact factor: 2.772

4.  Activation of JAK/STAT3 restores NK-cell function and improves immune defense after brain ischemia.

Authors:  Wei-Na Jin; Andrew F Ducruet; Qiang Liu; Samuel Xiang-Yu Shi; Michael Waters; Ming Zou; Kevin N Sheth; Rayna Gonzales; Fu-Dong Shi
Journal:  FASEB J       Date:  2018-01-08       Impact factor: 5.191

5.  Antigen-dependent versus -independent activation of invariant NKT cells during infection.

Authors:  Keli L Holzapfel; Aaron J Tyznik; Mitchell Kronenberg; Kristin A Hogquist
Journal:  J Immunol       Date:  2014-05-09       Impact factor: 5.422

6.  Human NK cells licensed by killer Ig receptor genes have an altered cytokine program that modifies CD4+ T cell function.

Authors:  Lin Lin; Chao Ma; Bo Wei; Najib Aziz; Raja Rajalingam; Susy Yusung; Henry A Erlich; Elizabeth A Trachtenberg; Stephan R Targan; Dermot P B McGovern; James R Heath; Jonathan Braun
Journal:  J Immunol       Date:  2014-06-16       Impact factor: 5.422

Review 7.  Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology.

Authors:  Richard M Ransohoff
Journal:  Immunity       Date:  2009-11-20       Impact factor: 31.745

8.  NK and NKT cell dynamics after rituximab therapy for systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Eliana A G Reis; Daniel A Athanazio; Isabella Lima; Natália Oliveira e Silva; Jorge Clarencio S Andrade; Ronden N Jesus; Lúcio M Barbosa; Mitermayer G Reis; Mittermayer B Santiago
Journal:  Rheumatol Int       Date:  2008-09-28       Impact factor: 2.631

9.  Transcriptome analysis of porcine PBMCs after in vitro stimulation by LPS or PMA/ionomycin using an expression array targeting the pig immune response.

Authors:  Yu Gao; Laurence Flori; Jérome Lecardonnel; Diane Esquerré; Zhi-Liang Hu; Angélique Teillaud; Gaëtan Lemonnier; Francois Lefèvre; Isabelle P Oswald; Claire Rogel-Gaillard
Journal:  BMC Genomics       Date:  2010-05-11       Impact factor: 3.969

10.  Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology.

Authors:  Junwei Hao; Ruolan Liu; Wenhua Piao; Qinghua Zhou; Timothy L Vollmer; Denise I Campagnolo; Rong Xiang; Antonio La Cava; Luc Van Kaer; Fu-Dong Shi
Journal:  J Exp Med       Date:  2010-08-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.